OPINION

US move affects Africa's vax drive

Oped, Ebere Okereke, Published on 07/06/2022

» The US Food and Drug Administration's recent decision to limit the use of the Johnson & Johnson Covid-19 vaccine to adults who cannot or will not get another vaccine will have profound consequences for African countries. The FDA said its move reflected the risk that the vaccine might cause a rare blood-clotting syndrome. But the decision shows that, even after two years of the pandemic, the needs of people in low- and middle-income countries, and Africans in particular, remain an afterthought for leading global health authorities.